Evidence map

ArticleClinical pharmacology and therapeutics2025

Duration of Time Intervals for Risk Minimization Measure Effectiveness Studies.

Sharon C M Essink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 39856533